Boardroom Alpha
Boardroom Alpha
CLIR · Current Report (Form 8-K) · Filed March 4, 2026

Clearsign Technologies Corp — Current Report (Form 8-K)

Form
8-K
Filed
March 4, 2026
Period
Feb 26, 2026
Ticker
CLIR
Accession
0001104659-26-023536
Boardroom Alpha · Filing insights

Stockholders approved a reverse stock split (ratio at Board discretion) to meet Nasdaq listing rules; adjournment approved.

About Clearsign Technologies Corp
Market cap
$24M
1Y TSR
−23.2%
3Y TSR
−29.4%
Board grade
C-
Sector
Industrials
CEO
Colin James Deller
Last annual meeting: Jun 8, 2026 · View full Clearsign Technologies Corp profile →
 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 26, 2026

 

CLEARSIGN TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in charter)

 

Delaware   001-35521   26-2056298

(State or other jurisdiction of
incorporation)

  (Commission File Number)   (IRS Employer
Identification No.)

 

8023 E. 63rd Place, Suite 101

Tulsa, Oklahoma 74133

(Address of Principal Executive Offices and Zip Code)

 

(918) 236-6461

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)

 

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

¨ 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(e)-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
common stock   CLIR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

On February 26, 2026, ClearSign Technologies Corporation (the “Company”) held a special meeting of stockholders (the “Special Meeting”). At the beginning of the Special Meeting, there were 35,968,485 shares of the Company’s common stock, par value $0.0001 per share (the “common stock”), present or represented by proxy, which represented 67.09% of the voting power of the Company’s outstanding shares of voting stock entitled to vote at the Special Meeting, and which constituted a quorum for the transaction of business. Holders of common stock were entitled to one vote for each share of common stock held as of the close of business on January 22, 2026. Summarized below are the final voting results for each proposal submitted to a vote of the stockholders at the Special Meeting. The two proposals below are each described in more detail in the definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (the “SEC”) on February 2, 2026.

 

Proposal 1. Approval of an amendment to the Company’s certificate of incorporation, as amended, to effect a reverse stock split of the Company’s outstanding common stock, at a ratio between 1-for-2 and 1-for-10, to be determined at the discretion of the Company’s board of directors (the “Board”), for the purpose of complying with the Nasdaq Listing Rules, subject to the Board’s discretion to abandon such amendment.

 

For   Against   Abstentions 
 26,667,027    9,224,242    77,216 

 

The foregoing proposal was approved. There were no broker non-votes on this proposal.

 

Proposal 2. Approval of one or more adjournments of the Special Meeting.

 

For   Against   Abstentions 
 27,887,899    7,865,883    214,703 

 

The foregoing proposal was approved. There were no broker non-votes on this proposal.

 

 

 

 

Item 5.08Shareholder Director Nominations.

 

On February 26, 2026, the Board determined to hold its 2026 annual meeting of stockholders (the “Annual Meeting”) on June 8, 2026. The Board also fixed the close of business on April 13, 2026, as the record date for determining the stockholders of record who will be entitled to vote at the Annual Meeting. Additional details regarding the Annual Meeting, including the time and location, will be set forth in the Company’s definitive proxy statement on Schedule 14A for the Annual Meeting to be filed with the SEC.

 

Because the date of the Annual Meeting has been changed by more than thirty (30) days from the anniversary of the Company’s 2025 annual meeting of stockholders, the Company is providing deadlines regarding the submission of stockholder proposals pursuant to Rule 14a-8 (“Rule 14a-8”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for the Annual Meeting. In order for a stockholder proposal, submitted pursuant to Rule 14a-8, to be considered timely for inclusion in the Company’s proxy statement and form of proxy for the Annual Meeting, such proposal must be received by the Company by March 14, 2026, which the Company has determined is a reasonable time before the Company plans to begin printing and mailing its proxy materials. Therefore, in order for a stockholder to submit a proposal for inclusion in the Company’s proxy materials for the Annual Meeting, the stockholder must comply with the requirements set forth in Rule 14a-8, including with respect to the subject matter of the proposal, and must deliver the proposal and all required documentation to the Company at its principal executive offices at the address set forth above no later than March 14, 2026. The public announcement of an adjournment or postponement of the date of the Annual Meeting will not commence a new time period (or extend any time period) for submitting a proposal pursuant to Rule 14a-8.

 

In accordance with the Company’s amended and restated bylaws (the “Bylaws”), because the date of the Annual Meeting is more than thirty (30) days before the anniversary date of the immediately preceding 2025 annual meeting of stockholders, stockholder proposals submitted outside of the Rule 14a-8 process and nominations for election to the Board at the Annual Meeting, even if the nomination is not to be included in the proxy statement for such meeting, must be received by the Company’s Corporate Secretary no later than the close of business on the later of (i) the 120th day prior to the Annual Meeting or (ii) the 10th day following the day on which the Company first publicly announces the date of the Annual Meeting. Accordingly, notice of stockholder proposals or director nominations under the Bylaws for the Annual Meeting must be received no later than March 14, 2026.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 4, 2026

 

  CLEARSIGN TECHNOLOGIES CORPORATION
     
  By: /s/ Colin James Deller
  Name: Colin James Deller
  Title: Chief Executive Officer

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Clearsign Technologies Corp (CLIR)

Reference

Frequently asked questions

When did Clearsign Technologies Corp file this 8-K?
Clearsign Technologies Corp (CLIR) filed this Current Report (Form 8-K) with the SEC on March 4, 2026. The accession number assigned by EDGAR is 0001104659-26-023536.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders approved a reverse stock split (ratio at Board discretion) to meet Nasdaq listing rules; adjournment approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Clearsign Technologies Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Clearsign Technologies Corp has filed under CIK 1434524, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer